Scientists are designing new psychedelic-inspired drugs that don’t yet exist, which might have effects no one can yet describe.
New year, new you.
The country’s medical regulator has rejected an application to have MDMA and psilocybin legalised for clinical use, citing a lack of evidence.
The non-profit Freedom to Operate used research from chemists and crystallographers to argue in a legal filing that Compass’ form of synthetic psilocybin is not a new invention.
Long wait times, minimal therapy, and wrong dosing are some of the bad experiences clients say they’ve had with Mindbloom, a ketamine company. It and other psychedelic tech startups are raising questions about the limits of telemedicine in this field.
French photographer Mathias de Lattre's project "Mother's Therapy" examines the relationship between mental illness and psychedelic therapies.
The latest data shows the highest rates of psychedelic use among college students since 1982.
Observers are split on the consequences of “speed-toading” using the venom, called bufo, as a cure for the ills of the modern world.
But it may expose you to misinterpreted and distressing information along the way.